About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1662 record(s)
Req # A-2022-000693
Adverse Drug Reactions (ADRs). Report numbers: E2B_05373176, E2B_05379629, E2B_05354467, E2B_05418935, E2B_02802085, E2B_03551753, E2B_04227694, E2B_05322086, E2B_00811534, 00993383.Organization: Health Canada
November 2022
Req # A-2022-000700
Adverse Drug Reactions (ADRs). Report numbers: E2B_03318145, E2B_05337204, E2B_02766186, E2B_02529970, E2B_03577909, E2B_05223333, E2B_03819094, E2B_04814754, E2B_03256289, E2B_05378319.Organization: Health Canada
November 2022
Req # A-2022-000710
Adverse Drug Reactions (ADRs) for HUMAN C1 ESTERASE INHIBITOR. Report numbers: E2B_05420465, E2B_05485462, E2B_05454818, E2B_05510805, E2B_05426658, E2B_05426521. ADRs for Pantoprazole sodium. Report numbers: E2B_05462886, E2B_05479825, E2B_05467508, E2B_05436471.Organization: Health Canada
November 2022
Req # A-2022-000716
Adverse Drug Reaction (ADR) for Entyvio. Report number: E2B_05505099.Organization: Health Canada
November 2022
Req # A-2022-000724
Adverse Drug Reactions (ADRs). Report numbers: E2B_02522906, 000662433.Organization: Health Canada
November 2022
Req # A-2022-000727
Adverse Drug Reactions (ADRs) for Morphine. Report numbers: 000997713, 000999686. ADRs for Hydromorphone. Report numbers: 001000721, E2B_05506118. ADRs for Heparin. Report numbers: E2B_05512597, 000998905, 000996381. ADR for Midazolam. Report number: 000999431.Organization: Health Canada
November 2022
Req # A-2022-000732
Adverse Drug Reactions (ADRs). Report numbers: E2B_05423342, 000956920, E2B_05457955.Organization: Health Canada
November 2022
Req # A-2022-000734
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-075252-54, Assessment of Modern Treaty Implications - Compliance.Organization: Health Canada
November 2022
Req # A-2022-000746
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-075203-177.Organization: Health Canada
November 2022
Req # A-2022-000759
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-107992-496.Organization: Health Canada
November 2022